Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Young, Empowered & Strong: Web-Based Symptom Monitoring and Self-Management for Young Adult Breast Cancer Survivors
Young, Empowered & Strong: Web-Based Symptom Monitoring and Self-Management for Young Adult Breast Cancer Survivors

Young, Empowered & Strong: Web-Based Symptom Monitoring and Self-Management for Young Adult Breast Cancer Survivors

Clinicaltrials.gov identifier:
NCT04906200

Quality of Life
Women diagnosed with breast cancer between the ages of 15-39

Study Contact Information:

For additional information, please contact:
The Jamesline jamesline@osumc.edu


Young, Empowered & Strong: Web-Based Symptom Monitoring and Self-Management for Young Adult Breast Cancer Survivors (YES Study)

About the Study

The goal of this study is to measure whether a web-based patient-reported symptom monitoring and self management portal, Young, Empowered & Strong (YES), improves the quality of life of young breast cancer survivors when compared to standard of care symptom management.
 

Type of Study 

This is a study with two separate treatment groups.      

Participants are placed into one of two study groups by chance, and neither the participants nor the researchers choose the group into which the participants are placed.

  • Group A participants will receive access to the Young, Empowered and Strong (YES) portal.
  • Group B participants will not receive access to the YES portal.

 

What the Study Involves

Participants will be randomly placed into one of two groups. Participants in both groups will complete a total of 4 surveys over 9 months. 

  • Participants in Group A will receive access to the YES portal for 9 months, and will complete surveys at 0, 3, 6, and 9 months.  
  • Participants in Group B will receive standard treatment (no access to the YES portal) and will complete surveys at 0, 3, 6, and 9 months. After 9 months, participants in group B will be given access to the YES portal for 3 months. 


Study Sites

Massachusetts 

  • Boston, MA
    Dana Farber Cancer Institute
    Contact: Ann Partridge, MD by phone: 617-582-7942 or by email: Ann_Partridge@dfci.harvard.edu
    Contact: Craig Snow, MHA by phone: 617-582-7942 or by email: craig_snow@dfci.harvard.edu     
    Lead Researcher: Ann H Partridge, MD         

New York

  • New York, NY
    Columbia University Medical Center
    Contact: Dawn Hershman, MD, MS by phone: 212-305-1945 or by email: dlh23@cumc.columbia.edu      

Ohio

  • Columbus, OH
    Ohio State University Comprehensive Cancer Center
    Contact: Michelle Naughton, PhD by phone: 614-293-6390 or by email: Michelle.Naughton@osumc.edu      
    Lead Researcher: Michelle Naughton, PhD         
This Study is Open To:

Women ages 15-39 (at diagnosis of breast cancer) who were diagnosed with 0-III breast cancer within the last 3 years.

This Study is Not Open To:
  • People currently younger than age 15 or older than age 42.
  • People who have been diagnosed with or recurrent breast cancer.